In an animal hydrocephalus model, EPO treatment significantly mitigated the dilation of the cerebral ventricles in obstructive hydrocephalus by augmenting the expression of AQP4 (Rizwan Siddiqui et al., 2018). The gene discussed is AQP4; the disease is obstructive hydrocephalus.